PMH40 12-MONTH TREATMENT DISCONTINUATION RATES IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH RISPERIDONE LONG ACTING INJECTION (RLAI): INTERIM RESULTS FROM THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY PROJECT CONDUCTED IN SPAIN, AUSTRALIA AND BELGIUM

Verfasser: Olivares, JM
Emmerson, B
Peuskens, J
Diels, JK
Caleo, S
Povey, M
Lam, A
Dokumenttyp: Artikel
Erscheinungsdatum: 2007
Reihe/Periodikum: Value in Health ; volume 10, issue 3, page A83 ; ISSN 1098-3015
Verlag/Hrsg.: Elsevier BV
Schlagwörter: Public Health / Environmental and Occupational Health / Health Policy
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26613091
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://dx.doi.org/10.1016/s1098-3015(10)68791-8